CORDIS · 909881 · FP7
TCM-VASC Discovery of bioactive natural compounds from Traditional Chinese Medicines (TCMs) used against Cardiovascular Disease (CVD)
Coordinator: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN)
Major aim of TCM-VASC is the discovery and characterisation of bioactive natural compounds from medicinal plants successfully used for centuries in Traditional Chinese Medicine (TCM) against Cardiovascular Disease (CVD). The discovery of such compounds is of great interest since CVD is the number one cause of mortality and morbidity worldwide. For many TCMs beneficial action on CVD are documented, but their mechanisms of action and the responsible bioactive compounds are largely unknown. The identification of bioactive compounds that are responsible for the efficacy of TCMs will have a big so…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €15k awarded to the consortium. The project runs over approximately 1 year from 2015-01-01 to 2015-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from CN
see all →- MESHWIMAX — Mesh WiMAX Management and Operatin, and Performance Analysis and Optimization909371 · FP7 · €15k
- COFRICTION — Optimization of the corrosion resistance of Friction Stir Welds in High Strenght Aluminium Alloys912487 · FP7 · €15k
- MMMDT — Multi-scale Modelling of Mechanical Damage to Tomatoes912847 · FP7 · €15k
- CHINAINNOVATION — GLOBALIZATION, INSTITUTIONAL REFORM, ANDCHINA’S INNOVATION CHALLENGES911303 · FP7 · €15k
- RHINOSPEC — Dissecting speciation using a genomics approach910243 · FP7 · €15k
- TOP — Trophodynamics of Organic Pollutants Studied by Compound-Specific Isotope Analysis909291 · FP7 · €15k
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the MC-IIFR funding scheme.
- What is the EU contribution?
- The European Commission contributes €15k toward a total project budget of €15k.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN).
- What is the project timeline?
- The project runs from 2015-01-01 to 2015-12-31 — approximately 1 year.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 909881.